The impact of antimicrobial resistance and aging in VAP outcomes: experience from a large tertiary care center.

<h4>Background</h4>Ventilator associated pneumonia (VAP) is a serious infection among patients in the intensive care unit (ICU).<h4>Methods</h4>We reviewed the medical charts of all patients admitted to the adult intensive care units of the Massachusetts General Hospital that...

Full description

Bibliographic Details
Main Authors: Marios Arvanitis, Theodora Anagnostou, Themistoklis K Kourkoumpetis, Panayiotis D Ziakas, Athanasios Desalermos, Eleftherios Mylonakis
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089984&type=printable
_version_ 1826799023747497984
author Marios Arvanitis
Theodora Anagnostou
Themistoklis K Kourkoumpetis
Panayiotis D Ziakas
Athanasios Desalermos
Eleftherios Mylonakis
author_facet Marios Arvanitis
Theodora Anagnostou
Themistoklis K Kourkoumpetis
Panayiotis D Ziakas
Athanasios Desalermos
Eleftherios Mylonakis
author_sort Marios Arvanitis
collection DOAJ
description <h4>Background</h4>Ventilator associated pneumonia (VAP) is a serious infection among patients in the intensive care unit (ICU).<h4>Methods</h4>We reviewed the medical charts of all patients admitted to the adult intensive care units of the Massachusetts General Hospital that went on to develop VAP during a five year period.<h4>Results</h4>200 patients were included in the study of which 50 (25%) were infected with a multidrug resistant pathogen. Increased age, dialysis and late onset (≥ 5 days from admission) VAP were associated with increased incidence of resistance. Multidrug resistant bacteria (MDRB) isolation was associated with a significant increase in median length of ICU stay (19 vs. 16 days, p=0.02) and prolonged duration of mechanical ventilation (18 vs. 14 days, p=0.03), but did not impact overall mortality (HR 1.12, 95% CI 0.51-2.46, p=0.77). However, age (HR 1.04 95% CI 1.01-1.07, p=0.003) was an independent risk factor for mortality and age ≥ 65 years was associated with increased incidence of methicillin-resistant Staphylococcus aureus (MRSA) infections (OR 2.83, 95% CI 1.27-6.32, p=0.01).<h4>Conclusions</h4>MDRB-related VAP is associated with prolonged ICU stay and mechanical ventilation. Interestingly, age ≥ 65 years is associated with MRSA VAP.
first_indexed 2024-12-23T20:42:19Z
format Article
id doaj.art-81d961935c00468c8e5217f50a5057ef
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2025-03-17T00:28:30Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-81d961935c00468c8e5217f50a5057ef2025-02-21T05:37:24ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0192e8998410.1371/journal.pone.0089984The impact of antimicrobial resistance and aging in VAP outcomes: experience from a large tertiary care center.Marios ArvanitisTheodora AnagnostouThemistoklis K KourkoumpetisPanayiotis D ZiakasAthanasios DesalermosEleftherios Mylonakis<h4>Background</h4>Ventilator associated pneumonia (VAP) is a serious infection among patients in the intensive care unit (ICU).<h4>Methods</h4>We reviewed the medical charts of all patients admitted to the adult intensive care units of the Massachusetts General Hospital that went on to develop VAP during a five year period.<h4>Results</h4>200 patients were included in the study of which 50 (25%) were infected with a multidrug resistant pathogen. Increased age, dialysis and late onset (≥ 5 days from admission) VAP were associated with increased incidence of resistance. Multidrug resistant bacteria (MDRB) isolation was associated with a significant increase in median length of ICU stay (19 vs. 16 days, p=0.02) and prolonged duration of mechanical ventilation (18 vs. 14 days, p=0.03), but did not impact overall mortality (HR 1.12, 95% CI 0.51-2.46, p=0.77). However, age (HR 1.04 95% CI 1.01-1.07, p=0.003) was an independent risk factor for mortality and age ≥ 65 years was associated with increased incidence of methicillin-resistant Staphylococcus aureus (MRSA) infections (OR 2.83, 95% CI 1.27-6.32, p=0.01).<h4>Conclusions</h4>MDRB-related VAP is associated with prolonged ICU stay and mechanical ventilation. Interestingly, age ≥ 65 years is associated with MRSA VAP.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089984&type=printable
spellingShingle Marios Arvanitis
Theodora Anagnostou
Themistoklis K Kourkoumpetis
Panayiotis D Ziakas
Athanasios Desalermos
Eleftherios Mylonakis
The impact of antimicrobial resistance and aging in VAP outcomes: experience from a large tertiary care center.
PLoS ONE
title The impact of antimicrobial resistance and aging in VAP outcomes: experience from a large tertiary care center.
title_full The impact of antimicrobial resistance and aging in VAP outcomes: experience from a large tertiary care center.
title_fullStr The impact of antimicrobial resistance and aging in VAP outcomes: experience from a large tertiary care center.
title_full_unstemmed The impact of antimicrobial resistance and aging in VAP outcomes: experience from a large tertiary care center.
title_short The impact of antimicrobial resistance and aging in VAP outcomes: experience from a large tertiary care center.
title_sort impact of antimicrobial resistance and aging in vap outcomes experience from a large tertiary care center
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089984&type=printable
work_keys_str_mv AT mariosarvanitis theimpactofantimicrobialresistanceandaginginvapoutcomesexperiencefromalargetertiarycarecenter
AT theodoraanagnostou theimpactofantimicrobialresistanceandaginginvapoutcomesexperiencefromalargetertiarycarecenter
AT themistokliskkourkoumpetis theimpactofantimicrobialresistanceandaginginvapoutcomesexperiencefromalargetertiarycarecenter
AT panayiotisdziakas theimpactofantimicrobialresistanceandaginginvapoutcomesexperiencefromalargetertiarycarecenter
AT athanasiosdesalermos theimpactofantimicrobialresistanceandaginginvapoutcomesexperiencefromalargetertiarycarecenter
AT eleftheriosmylonakis theimpactofantimicrobialresistanceandaginginvapoutcomesexperiencefromalargetertiarycarecenter
AT mariosarvanitis impactofantimicrobialresistanceandaginginvapoutcomesexperiencefromalargetertiarycarecenter
AT theodoraanagnostou impactofantimicrobialresistanceandaginginvapoutcomesexperiencefromalargetertiarycarecenter
AT themistokliskkourkoumpetis impactofantimicrobialresistanceandaginginvapoutcomesexperiencefromalargetertiarycarecenter
AT panayiotisdziakas impactofantimicrobialresistanceandaginginvapoutcomesexperiencefromalargetertiarycarecenter
AT athanasiosdesalermos impactofantimicrobialresistanceandaginginvapoutcomesexperiencefromalargetertiarycarecenter
AT eleftheriosmylonakis impactofantimicrobialresistanceandaginginvapoutcomesexperiencefromalargetertiarycarecenter